Avelumab: Phase III started

Merck and Pfizer began the open-label, international Phase III JAVELIN Gastric 300 trial to compare 10 mg/kg IV avelumab every 2 weeks vs. investigator’s choice of chemotherapy in 330 patients. Pfizer...